If miRNAs specific for C9orf72 ALS/FTD patients are found and confirmed to be stable and secreted in the CSF (or even blood), these could be utilized as an invaluable readout for therapy efficacy. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.